Japanese Man Falls Unconscious After Taking ED Drug From China
This article was originally published in PharmAsia News
A Japanese man in Hiroshima fell unconscious after taking an erectile dysfunction drug made in China that has not been approved in Japan. The man, in his 30s, imported 24 capsules of Nangenzengzhangsu, and took the capsules once a day since the end of January. On Feb. 21, he fell unconsciousness at work and was rushed to the hospital. Two drug ingredients were found in the capsules, blood sugar lowering glibenclamide and sildenafil (the active ingredient in Pfizer's Viagra). The amount of glibenclamide contained in the capsules was found to greatly exceed the allowable level set forth in the Pharmaceutical Law. (Click for more-Japanese language
You may also be interested in...
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.